Figure 1

Identification process for post-marketing reports of suspected AEs related to clotrimazole, econazole, ketoconazole and miconazole, from the first quarter of 2004 to the third quarter of 2022.
Identification process for post-marketing reports of suspected AEs related to clotrimazole, econazole, ketoconazole and miconazole, from the first quarter of 2004 to the third quarter of 2022.